382150.KQ
Oncocross Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 3,450.00
−2.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.06x
- Price / sales
- 104.92x
- Price / cash flow
- -5.80x
Enterprise value
- Enterprise value
- KRW 16.7B
- EV / sales
- 42.12x
- EV / EBITDA
- -1.59x
- EV / EBIT
- -1.70x
- Market cap
- KRW 41.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026